Variant ID: 8-6417834-T-C

NM_001147.2(ANGPT2):c.288+2334A>G

This variant was identified in 2 publications




Publications:


Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Plos One
I Makhoul, VK Todorova, ER Siegel, SW Erickson, I Dhakal, VR Raj, JY Lee, MS Orloff, RJ Griffin, RS Henry-Tillman, S Klimberg, LF Hutchins, SA Kadlubar
Publication Date: 2017

Variant appearance in text: rs12547077
PubMed Link: 28045923
PubMed Central Link
Variant Present in the following documents:
  • pone.0168550.s006.xlsx
  • pone.0168550.s005.xlsx
  • pone.0168550.s007.xlsx
View BVdb publication page



MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD.

Oncotarget
C Ménard, FA Rezende, K Miloudi, A Wilson, N Tétreault, P Hardy, JP SanGiovanni, V De Guire, P Sapieha
Publication Date: 2016-04-12

Variant appearance in text: rs12547077
PubMed Link: 27015561
PubMed Central Link
Variant Present in the following documents:
  • oncotarget-07-19171-s004.xlsx
View BVdb publication page



Alternative transcript annotations:

Transcript cDNA Protein Consequence Exon Intron
ENST00000325203.5 c.288+2334A>G - intron_variant - 1/8
ENST00000338312.6 c.288+2334A>G - intron_variant - 1/7
ENST00000344683.5 c.2214+60384T>C - intron_variant - 12/13
ENST00000415216.1 c.288+2334A>G - intron_variant - 1/8
ENST00000519221.1 n.321+60384T>C - intron_variant,non_coding_transcript_variant - 4/4
ENST00000521129.1 n.372+60384T>C - intron_variant,non_coding_transcript_variant - 4/4
ENST00000523120.1 c.288+2334A>G - intron_variant - 1/7
NM_001118887.2 c.288+2334A>G - intron_variant - 1/8
NM_001118888.2 c.288+2334A>G - intron_variant - 1/7
NM_001147.3 c.288+2334A>G - intron_variant - 1/8
NM_001322042.2 c.2214+60384T>C - intron_variant - 12/14
NM_001363979.1 c.2214+60384T>C - intron_variant - 12/13
NM_001363980.2 c.1936-61141T>C - intron_variant - 9/10
NM_024596.5 c.2214+60384T>C - intron_variant - 12/13